INVESTING IN EUROPE - SCALING GLOBALLY

 

CONVERGENCE PARTNERS

Convergence Partners was formed in 2018 by experienced venture capital - and operational experts with a vision to establish a venture capital firm that actively supports the internationalisation and market access of European technology innovators to the 4 largest healthcare markets: US, China, India and Germany. Whereas our current investment focus is on EU HealthTech startups, Convergence is able to open its cross-border acceleration platform to any DeepTech company that is keen to accelerate growth through rapid internationalisation.

Please get in touch with us to discuss your growth and investment plans.

INVESTMENT FOCUS

Medical Devices

Diagnostics

Digital Health

KEY INVESTMENT SELECTION CRITERIA

We are interested to hear from innovative EU HealthTech companies that have commercialised their technologies and are looking to accelerate scale-up.

Key Investment Selection Criteria

  • B2B-focused HealthTech company with strong
    international growth potential and ambitions
  • Highly scalable, IP-driven business model
  • Commercialised product with first revenues

Typical Deal Structure

  • Significant equity minority stake
  • Ticket size up to EUR 5M initially - additional capital
    reserved for follow-on investments
  • Board representation to support management
    teams as an active sparring partner

OUR TEAM

The Convergence Team is represented in Switzerland, Germany and Spain and has additional partner hubs in Asia and the US to effectively support the internationalization of our portfolio companies. The investment team is supported by experienced venture-and operating partners, a top-class advisory board and experienced local landing & scale-up partners.

Daniel Koppelkamm
Founder, Managing Partner & Investment Committee Member
Raj Airey
Founding Partner & Investment Committee Member
Mikael von Euw
Operating Partner & Investment Committee Member
Stefan Säuberlich
Investment Director
Qiwei Zhang
Analyst
Uwe Fischer
Head of Marketing & Social Media
Dr. Laura Johnson
Venture Partner, Germany
Dweep Chanana
Venture Partner, Switzerland
Gerard Valverde
Venture Partner, Spain
Xingyue Chen
Venture Partner, Benelux
Boye Hartmann
Venture Partner, Nordics
Tal Gal On
Venture Partner, Israel
Dr. Songia Wen
Venture Partner, China
Shervin Sharghy
Venture Partner, Hong Kong
Harish Natarajan
Venture Partner, India
Dieter Kondek
Venture Partner, USA
Prof. Erich Reinhardt
Advisor
Luigi Espasiano (MD)
Advisor
Dr. Patrick Pfeffer
Advisor
Dr. Renchen Liu
Advisor

OUR TEAM

NEWS & UPDATES

Medical Valley, CP and Siemens Healthineers are establishing a joint China landing hub at Shanghai Zhangjiang Park.       read more

 

CP invests into b-RayZ AG, which has developed a AI technology for breast cancer diagnostics.      read more

 

CP invests into neuroCare Group, a fast-growing German HealthTech company
read more

 
© Copyright 2022 Convergence Partners AG. Implementation by progressio
We use cookies to enhance your experience. More info
Got it!